AC
Actuate Therapeutics Inc (ACTU)
NASDAQ·Healthcare·Biotechnology
$1.99
-2.93%
Mkt Cap $68.45M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$21.00
Range $21.00 – $21.00
Implied Upside
+955.3%
Consensus $21.00 vs current $1.99
NASDAQ·Healthcare·Biotechnology
$1.99
-2.93%
Mkt Cap $68.45M
No recent rating data.
Price Target (1 analysts)
$21.00
Range $21.00 – $21.00
+955.3%
Consensus $21.00 vs current $1.99